Sarah Oelsner is an Analyst with Catenion and lives in Berlin.
She studied Pharmacy at the University of Heidelberg and the University of Zaragoza, Spain.
She received her license as a Pharmacist after completing her pre-registration year at the Novartis Institute of Biomedical Research (NIBR), Basel, where she worked on COPD and inflammation. During her Ph.D. at the Georg-Speyer-Haus, Frankfurt/M., Sarah developed various CAR-modified lymphocytes to target hematological malignancies.
In her spare time she is a long-distance runner and an active member at her hometown’s triathlon club. She enjoys traveling and studying new languages.
After studying Pharmacy in Heidelberg and Zaragoza Sarah completed a Ph.D. in Immunooncology and at the Georg-Speyer-Haus/ University of Frankfurt. She also earned a distance-leaning degree in Pharmaceutical Bioinformatics at the University of Uppsala, Sweden.
- Cellular and gene therapies
- Immunology & Immunooncology
- Cancer Biology
- Patient Medication Management